ortuneRock (China) of Beijing completed a $24 million funding that it will use to advance its portfolio of novel protein drugs. Of the total, $20 million is earmarked for drug development and building a GMP manufacturing facility in Tianjin, which will be spun off into a separate company. The remaining $4 million will underwrite general corporate purposes, including a planned IPO.
Help employers find you! Check out all the jobs and post your resume.